期刊文献+

应用单圈消融法行经皮肾去交感神经治疗难治性高血压的临床研究 被引量:2

Clinical study on application of single circle percutaneous renal sympathetic denervationin for the treatment of refractory hypertension
原文传递
导出
摘要 目的对比单圈消融法与螺旋消融法行经皮肾去交感神经(RSD)治疗难治性高血压的有效性和安全性。方法选择40例难治性高血压患者行RSD,随机分为单圈消融组(简称单圈组)和螺旋消融组(简称螺旋组),观察术前和术后6个月时的动态血压(ABPM)和心率变化,以及术后不良反应发生情况。结果与术前比较,两组患者术后6个月ABPM均显著下降,单圈组[(138.4±9.2/86.1±7.4)mm Hg vs(158.3±18.6/98.6±9.5)mm Hg,P<0.001],螺旋组[(145.5±12.0/91.3±8.2)mm Hg vs(156.4±19.8/96.8±8.4)mm Hg,P<0.05],二组心率均较术前显著下降,单圈组[(72.3±8.2)次/分vs(89.7±16.4)次/分,P<0.001],螺旋组[(78.3±10.3)次/分vs(86.5±14.8)次/分,P<0.05]。与螺旋组相比,单圈组ABPM和心率明显下降(P<0.05)。两组术后均无不良反应发生。结论应用单圈消融法行RSD治疗难治性高血压是有效和安全的,优于螺旋式消融法。 Objective To compare the effectiveness and safety of single circle and spiral percutaneous renal sympathetic denervation (RSD) in the treatment of refractory hypertension. Methods Forty patients with refractory hypertension treated with percutaneous renal sympathetic nerve ablation were randomly divided into single circle ablation group ( single circle group) and spiral ablation group( spiral group). The ambulatory blood pressure(ABPM) and the average heart rate were assessed before and 6 months after operation. The postoperative adverse reactions were also observed. Results The ABPM of two groups was decreased significantly at sixth month after operation compared with that before operation, [ single circle group ( 138.4±9.2/86.1 ±7.4 ) mmHg vs ( 158.3±18.6/98.6 ±9.5 ) mmHg, spiral group ( 145.5 ± 12.0/91.3 ±8.2 ) mmHg vs (156.4±19.8/96.8±8.4)mmHg, P〈0. 001 and 0.05 respectively]. At the same time the average heart rate was significantly lower than that before surgery [ single circle group (72.3 ±8.2)bpm vs (89.7 ±16.4 )bpm, spiral group ( 78.3 ± 10.3 ) bpm vs (86.5 ±14.8 ) bpm, P〈0.05 respectively ]. The ABPM and the heart rate of 6 months after operation were observed lower in single circle group than those in spiral grouP( P〈0.05, respectively). No adverse reactions were observed after operation in two groups. Conclusion The RSD treatment with single circle RSD in refractory hypertension is effective and safe, which maybe superior to that with spiral RSD. [ Chinese Journal of Cardiac Pacing and Electrophysiology,2015,29(6) :554-557]
出处 《中国心脏起搏与心电生理杂志》 2015年第6期554-557,共4页 Chinese Journal of Cardiac Pacing and Electrophysiology
基金 江苏省卫生厅基金资助项目(YG201308)
关键词 心血管病学 难治性高血压 去肾交感神经术 导管消融 射频电流 单圈消融 Cardiology Refractory hypertension Renal sympathetic denervation Catheter ablation, radiofrequence current Single circle ablation
  • 相关文献

参考文献9

  • 1Keamey PM, Wheltom M, Reynolds K, et al. Global burden of hyper- tension : analysis of worldwide data [ J ]. Lancet, 2005,365 ( 9455 ) : 217.
  • 2孙宁玲,霍勇,王继光,李南方,陶军,李勇,严晓伟,蒋雄京,李学旺.难治性高血压诊断治疗中国专家共识[J].中国介入心脏病学杂志,2013,21(2):69-74. 被引量:58
  • 3Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sym- pathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[ J]. Lancet,2009,373:1 275.
  • 4Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denerva-tion in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial) :a randomized controlled trial[ J ]. Lancet,2010,376: 1 903.
  • 5郭宗文,黄从新.肾交感神经及去交感神经对血压影响的研究[J].中国心脏起搏与心电生理杂志,2014,28(5):449-451. 被引量:3
  • 6Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial [ J ]. Clinical Cardiology, 2012,35 ( 9 ) : 528.
  • 7盛晓东,杨向军,金骁琦,朱宗成.应用盐水灌注射频消融导管行经皮肾去交感神经术治疗难治性高血压[J].中国心脏起搏与心电生理杂志,2014,28(6):520-522. 被引量:2
  • 8Ukena C, Mahfoud F, Spies A, et al. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension[ J]. Int J Cardiol,2013 ,167 :2 846.
  • 9Wang Z, Chen S,Zhou T, et al. Comparison of saline-irrigated cathe- ter vs temperature-controlled catheter for renal dencrvation in a ca- nine model[J]. Am J Hypertens,2015 May 1. pii: hpvOS1. [Epab ahead of print].

二级参考文献34

  • 1Calhoun DA,Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation, and treatment. A scientific statement fromthe American Heart Association Professional Education Committeeof the Council for High Blood Pressure Research. Hypertension,2008, 51:1403-1419.
  • 2Chobanian AV, Bakris GL, Black HR, et al. Joint NationalCommittee on Prevention,Detection,Evaluation, and Treatmentof High Blood Pressure. National Heart, Lung, and BloodInstitute; National Heart, Lung, and Blood Institute; NationalHigh Blood Pressure Education Program Coordinating Committee.Seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure.Hypertension, 2003,42 : 1206-1252.
  • 3Dahlof B,Sever PS, Poulter NR, et al. ASCOT Investigators.Prevention of cardiovascular events with an antihypertensiveregimen of amlodipine adding perindopril as required versusatenolol adding bendroflumethiazide as required, in the AngloScandinavian Cardiac Outcomes Trial-Blood Pressure LoweringArm ( ASCOT-BPLA) : a multicentre randomised controlled trial.Lancet,2005,366 : 895 -906.
  • 4Jamerson K,Weber MA, Bakris GL, et al. ACCOMPLISH TrialInvestigators. Benazepril plus amlodipine or hydrochlorothiazidefor hypertension in high-risk patients. N Engl J Med,2008,359:2417-2428.
  • 5Schmieder RE,Redon J, Grassi G,et al. ESH position paper:renal denervation - an interventional therapy of resistanthypertension. J Hypertens, 2012, 30:837-841.
  • 6Tsioufis C, Kordalis A, Flessas D, et al. Pathophysiology ofresistant hypertension : the role of sympathetic nervous system.Int J Hypertens, 2011,ID :642416.
  • 7Barajas L,Liu L, Powers K. Anatomy of the renal innervation:intrarenal aspects and ganglia of origin. Can J PhysiolPharmacol, 1992, 70:735-749.
  • 8Hering D,Mahfoud F, Walton AS, et al. Renal denervation inmoderate to severe CKD. J Am Soc Nephrol, 2012, 23 : 1250-1257.
  • 9Laurent S, Schlaich M, Esler M. New drugs, procedures, anddevices for hypertension. Lancet, 2012,380:591-600.
  • 10Aucott L,Poobalan A,Smith WC,et al. Effects of weight loss inoverweight/obese individuals and long-term hyper-tensionoutcomes: a systematic review. Hypertension, 2005,45 : 1035-1041.

共引文献60

同被引文献11

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部